MCL Featured Stories
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Protecting Access to Medicare Act (PAMA) reform and celebrate an exciting milestone for Dr. Pritt’s “Creepy Dreadful Wonderful Parasites” blog.
We’ve created two new oral fluid specimen collection videos for controlled substance monitoring. The first video is designed to support healthcare professionals by outlining how to safely and effectively oversee a patient’s specimen collection. The second is from the patient’s perspective, giving them a step-by-step guide for what to expect during the collection process.
Learn more about how Mayo Clinic Laboratories approach to whole transcriptome RNA sequencing provides the most comprehensive detection of gene fusions in solid tumors through use of next-generation sequencing to identify fusions in 1,445 genes.
Outline service recovery strategies to maintain trust, loyalty, and a positive relationship with customers.
Mayo Clinic Laboratories is monitoring Winter Storm Gianna with potential impact to the southeastern United States.
Viral and pharmacogenomic testing help clinicians detect infection early, tailor immunosuppression, and improve long-term outcomes for organ transplant recipients.
PACE/FL - Register now – April 14, 2026: An overview of a practical strategy used to support compliance with CAP and CLIA requirements for temperature and humidity control of instruments and equipment used in laboratory testing systems.
In the fourth quarter of 2025, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests.
In this episode of the “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, is joined by colleagues Wendy Daigle and Ellen Dijkman Dulkes to discuss identifying meaningful goals for a laboratory outreach program and taking steps to achieve them.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss 2026 trends.
Mayo Clinic Laboratories is monitoring Winter Storm Fern, a major winter weather event that is moving through a large portion of the United States. This storm could impact the FedEx hub in Memphis, TN and cause specimen delays from Jan. 22 through Jan. 29, 2026.
Matthew Binnicker, Ph.D., shares strategies to speed diagnostic innovation while safeguarding quality and patient trust.
Discover the right planning and problem-solving tools to help reach your goals, enhance outreach, and improve workflows.